2020 Targeted Translation Research Accelerator: Diabetes and Cardiovascular Disease.
Short time frame: Applications open April 3rd and Close April 20th
Maximum grant: $47 million available over four years from 2019-20 to 2022-23.
Large Grant Opportunity for an organisation to lead this initiative ensuring that the Accelerator delivers a number of outcomes, including
- the establishment through competitive processes of two research centres
- supports research projects through competitive processes
- targets investment and related support through partnership projects to progress promising drug and device development projects.
For further details please refer to the guidelines.
No comments:
Post a Comment